OXBT Share Price

Open 4.05 Change Price %
High 4.11 1 Day 0.02 0.50
Low 4.00 1 Week 0.00 0.00
Close 4.04 1 Month 0.00 0.00
Volume 190144 1 Year 0.00 0.00
52 Week High 29.42
52 Week Low 0.00
OXBT Important Levels
Resistance 2 4.14
Resistance 1 4.10
Pivot 4.05
Support 1 3.98
Support 2 3.94
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
MU 20.45 7.29%
MU 20.45 7.29%
MU 20.45 7.29%
More..
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
ANTH 2.03 38.10%
EMKR 8.45 31.01%
MBLX 0.32 28.00%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
HTCO 8.00 23.08%
ATEA 1.95 21.88%
ATEA 1.95 21.88%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
QKLS 0.12 -36.84%
More..

Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT)

OXBT Technical Analysis 1.5
As on 18th Sep 2014 OXBT Share Price closed @ 4.04 and we RECOMMEND Sell for LONG-TERM with Stoploss of 5.03 & Buy for SHORT-TERM with Stoploss of 4.02 we also expect STOCK to react on Following IMPORTANT LEVELS.
OXBT Target for December
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
Oxygen Biotherapeutics, Inc. ( NASDAQ USA Symbol : OXBT )
Sector : Health Care Biotechnology: Commercial Physical & Biological Resarch And Other Stocks in Same Sector
GNOM
3.14 -0.01 (-0.32 %)
LT : Strong Buy
ST : Buy
MAXY
2.53 -0.01 (-0.39 %)
LT : Buy
ST : Buy
NRCI
60.10 -0.65 (-1.07 %)
LT : Buy
ST : Buy
OXBT
4.04 0.02 (0.50 %)
LT : Sell
ST : Buy
OXBT Other Details
Segment EQ
Market Capital 28934008.00
Sector Health Care Biotechnology: Commercial Physical & Biological Resarch
Industry
Offical website
OXBT Address
OXBT
N/A
Interactive Technical Analysis Chart Oxygen Biotherapeutics, Inc. ( OXBT NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Oxygen Biotherapeutics, Inc.
OXBT Business Profile
Oxygen Biotherapeutics, Inc. (Oxygen Biotherapeutics) is engaged in the business of developing biotechnology products with a focus on oxygen delivery to tissue. As of April 30, 2011, the Company is developing Oxycyte, a systemic perfluorcarbon (PFC), product. It has developed a family of perfluorocarbon-based oxygen carriers for use in personal care, topical wound healing, and other topical indications. In addition, Oxygen Biotherapeutics has also have under development Vitavent, an oxygen exchange fluid for facilitating the treatment of lung conditions, and it has out-licensed its rights to a biosensor implant product that uses an enzyme process for measuring the glucose level in subcutaneous fluid. In November 2013, the Company acquired certain assets of Phyxius Pharma.